Champions Oncology (CSBR) vs eXoZymes (EXOZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Champions Oncology (CSBR) has outperformed eXoZymes (EXOZ) over the past year, losing 25.4% versus a loss of 59.0%. Champions Oncology is the larger company by market cap ($69.3 million vs $49.0 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CSBR | EXOZ |
|---|---|---|
| Share price | $4.98 | $5.27 |
| Market cap | $69.31M | $49.04M |
| 1-day change | +2.05% | -4.87% |
| YTD return | -29.38% | -49.17% |
| 1-year return | -25.38% | -58.96% |
| 5-year return | -51.59% | — |
| Forward P/E | 49.80 | — |
| EPS (TTM) | $-0.07 | $-1.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.31 | $18.40 |
| 52-week low | $4.59 | $4.35 |
| Distance from 52-week high | -40.07% | -71.36% |
| Analyst consensus | — | strong_buy |
| Average volume | 11.50K | 6.80K |
| Shares outstanding | 13.92M | 9.30M |
| Employees | 214 | 32 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CSBR has outperformed EXOZ by 33.6 percentage points over the past year.
About Champions Oncology
CSBR stock →Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform.
Healthcare · Biotechnology · 214 employees
About eXoZymes
EXOZ stock →eXoZymes, Inc. operates as a development stage biotechnology company.
Healthcare · Biotechnology · 32 employees
CSBR vs EXOZ FAQ
Which is bigger, Champions Oncology or eXoZymes?
Champions Oncology (CSBR) is larger, with a market capitalization of $69.31M compared with $49.04M for eXoZymes (EXOZ).
Which stock has performed better over the past year, CSBR or EXOZ?
CSBR returned -25.38% over the past 12 months, compared with -58.96% for EXOZ (price return, excluding dividends). Past performance does not predict future results.
Are Champions Oncology and eXoZymes in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.